2025年9月16日，个人护理用品公司Kenvue（KVUE）成交额为3.58亿美元，在当日美股中排第324名，成交额较昨日减少21.61%，当日成交量为1967.91万。 Kenvue（KVUE）于2025年9月16日跌0.66%，报18.13美元，该股过去5个交易日跌3.92%，整个9月跌12.46%，年初至今跌15.08%，过去52周跌22.46%。

Study reveals gaps in cough management in India, emphasizing need for scientific evaluation, rational prescribing, and ...

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian served as co-counsel to longtime client Boston Basketball Partners, ...

A recent study highlights improper categorization and treatment of cough in India. It emphasizes the overuse of antibiotics and fixed-dose combinations, urging a scientific approach to evaluation and ...

Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days ...

Beyond oral care, Kenvue is aligning its strategy with the government’s Healthy China 2030 initiative, a national plan to ...

Trump administration to link children’s deaths with COVID-19 vaccine; Kenvue’s CEO lobbied RFK Jr.; NIH on track to spend its full budget by end of the month.

Amid an outbreak of pertussis in Louisiana, Sen Bill Cassidy, MD (R-La.), penned a letter to HHS Secretary Robert F. Kennedy ...

Recent health developments include the FDA's approval for Apple Watch hypertension features, Belgian contraceptive storage ...

The CEO of the company that makes Tylenol has directly pleaded with Robert F. Kennedy Jr. not to link the drug to autism.

Kenvue’s interim CEO Kirk Perry met Robert F. Kennedy Jr. to try and dissuade him from listing Tylenol as a potential cause ...